{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-230711","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2026-05-19T20:01:45+00:00","discovered_at":"2026-05-19T20:03:02.588279+00:00","generated_at":"2026-05-19T20:05:10.412388+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Galera Therapeutics converts all Series B Preferred Stock into 42.8M common shares","bullets":["Converted 42,839.11 Series B preferred shares into 42,839,103 common shares on May 15, 2026.","No fractional shares were issued; holders will receive cash in lieu of fractional shares.","After conversion, no shares of Series B Preferred Stock remain outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-230711","json":"https://secwatch.observer/filing/0001193125-26-230711.json","markdown":"https://secwatch.observer/filing/0001193125-26-230711.md","text":"https://secwatch.observer/filing/0001193125-26-230711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/0001193125-26-230711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/d78370d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T20:05:10.412388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}